Johnson & Johnson (BCBA:JNJ)

Argentina flag Argentina · Delayed Price · Currency is ARS
13,125
-100 (-0.76%)
At close: Jul 8, 2025, 5:00 PM BRT
8.68%
Market Cap 471.18T
Revenue (ttm) 95.67T
Net Income (ttm) 23.36T
Shares Out n/a
EPS (ttm) 9,622.91
PE Ratio 20.17
Forward PE 14.68
Dividend 226.09 (1.71%)
Ex-Dividend Date May 27, 2025
Volume 7,131
Average Volume 10,836
Open 13,325
Previous Close 13,225
Day's Range 13,025 - 13,325
52-Week Range 10,425 - 14,775
Beta 0.41
RSI 66.16
Earnings Date Jul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Sector Healthcare
Founded 1886
Employees 138,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.